Stem definition | Drug id | CAS RN |
---|---|---|
antineoplastics, daunorubicin derivatives | 510 | 50935-04-1 |
None
Property | Value | Reference |
---|---|---|
MRTD (Maximum Recommended Therapeutic Daily Dose) | 1.32 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
None
None
None
None
None
Source | Code | Description |
---|---|---|
MeSH PA | D000903 | Antibiotics, Antineoplastic |
MeSH PA | D000970 | Antineoplastic Agents |
MeSH PA | D004791 | Enzyme Inhibitors |
MeSH PA | D059005 | Topoisomerase II Inhibitors |
MeSH PA | D059003 | Topoisomerase Inhibitors |
CHEBI has role | CHEBI:35610 | antineoplastic agents |
CHEBI has role | CHEBI:68495 | Type I cell-death inducers |
None
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 7.89 | acidic |
pKa2 | 10.98 | acidic |
pKa3 | 11.29 | acidic |
pKa4 | 11.9 | acidic |
pKa5 | 8.6 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
DNA topoisomerase 2-alpha | Enzyme | WOMBAT-PK |
ID | Source |
---|---|
D03414 | KEGG_DRUG |
52794-97-5 | SECONDARY_CAS_RN |
CHEBI:31359 | CHEBI |
CHEMBL474260 | ChEMBL_ID |
4552 | INN_ID |
E7437K3983 | UNII |
C0007308 | UMLSCUI |
D002360 | MESH_DESCRIPTOR_UI |
CHEMBL3989443 | ChEMBL_ID |
443831 | PUBCHEM_CID |
None